OpenAlex
PricingAboutJobs
Log inGet started
Work

PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?

HTML

Year: 2013
Type: article
Source: Current Pharmaceutical Design
DOI: 10.2174/13816128113199990303
Authors: Maciej Banach, Manfredi Rizzo, Milan Obradovic, Giuseppe Montalto, Jacek Rysz, Dimitri P. Mikhailidis, Esma R. Isenovic
Institution: Medical University of Lodz
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: PCSK9 inhibition, PCSK9, LDL cholesterol, LDL receptor, hyperlipidemia, statins, cardiovascular risk, lipid-lowering therapy, LDL receptor degradation
SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Sanofi, Regeneron Pharmaceuticals
OpenAlex ID: W2172156812
FWCI: 4.832
Cites: 90
Cited by: 59
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security